Skip to Content
  • Previous Rank
    -
  • Revenue 3 Yr Annual Growth Rate
    58%
  • Revenue 3 Yr Growth Rank
    7
  • EPS 3 Yr Annual Growth Rate
    88%
  • EPS 3 Yr Growth Rank
    10
  • Total Return 3 Yr Annual Rate
    28%
  • Total Return 3 Yr Rank
    46

A designer of a kind of modern medical alchemy, MiMedx creates tissue grafts from recovered placentas that are used to treat soft-tissue wounds.

Company Information

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Location
Marietta, Ga.
Industry
Pharmaceuticals
Sector
Health Care
Current Streak-
Years on List1
CEO
Parker Petit
Websitehttp://www.mimedx.com

Revenue, Net Income

Revenue past four quarters ($M)$264
Net Income past four quarters ($M)$15

Growth Rates and Ranks

Revenue 3 Yr Growth Rank7
Revenue 3 Yr Annual Growth Rate58%
EPS 3 Yr Growth Rank10
EPS 3 Yr Annual Growth Rate88%
Total Return 3 Yr Rank46
Total Return 3 Yr Annual Rate28%
Beat S&P 500 (9.6%)
yes
P/E Ratio54